Senators Introduce Bill Aimed to Support Fight to Cure Hep C

A new bill introduced to the U.S. Senate aims to increase funding and access for hepatitis C virus treatment in the ...

JUNE 27, 2025

Hepatology Telehealth Integrated With Opioid Treatment Can Improve Hepatitis C Outcomes

Patients with hepatitis C virus had increases in cure rates when hepatology telemedicine appointments were ...

JUNE 15, 2024

Disappointing Results for U.S. Hepatitis C Clearance Cascade

Only 34% of people with diagnosed hepatitis C virus in the United States have achieved viral clearance, according ...

JANUARY 13, 2024

Novel Methods Foster Successful HCV Treatment

Despite the availability of effective, curative treatment for hepatitis C virus, substantial gaps remain in care.

DECEMBER 25, 2023

Navigators Speed HCV Prior Authorization Insurance Coverage

Although the prior authorization process for direct-acting antiviral agents to treat hepatitis C has become ...

MAY 6, 2019

How Short Can We Go With DAAs for HCV?

It looks increasingly likely that the course of treatment for hep C can be shortened from 12 weeks—already a ...

FEBRUARY 5, 2019

Study May Lessen Controversy Over DAAs’ Relationship to Liver Cancer

Washington—Eradication of chronic infection with the hepatitis C virus with the new class of antiviral agents ...

JUNE 25, 2018

FDA Issues Black Box Warning for HBV Reactivation

The FDA is urging DAA manufacturers to place the warning labels on their drugs.

OCTOBER 6, 2016